Zimmer Biomet Stock Forecast
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ZBH analyst consensus
Consensus (28 analysts)
buy
Avg. price target
$107.23+20.29%
- Strong buy 3
- Buy 6
- Hold 19
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 28 Wall Street analysts covering Zimmer Biomet (2026-10-07), 9 rate the stock a buy or strong buy, 19 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $107.23, with a high estimate of $130.00 and a low estimate of $93.00. The average target implies upside of 20.3% from the current price of $89.14.
The spread between the highest and lowest targets is 39.8%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ZBH.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 11% |
| Buy | 6 | 21% |
| Hold | 19 | 68% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $93.00 | +4.33% |
| Average target | $107.23 | +20.29% |
| High target | $130.00 | +45.84% |